Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-05 7:16 pm Purchase |
2023-12-27 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 45,989,871 66.310% |
32,000,317 (+228.74%) |
Filing History |
| 2023-09-07 8:05 pm Purchase |
2023-08-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 13,989,554 37.450% |
8,568,949 (+158.08%) |
Filing History |
| 2023-09-06 4:24 pm Purchase |
2023-09-01 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
IAF, LLC | 3,133,914 9.990% |
397,899 (+14.54%) |
Filing History |
| 2023-08-25 8:40 pm Purchase |
2023-07-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 5,420,605 19.990% |
986,195 (+22.24%) |
Filing History |
| 2023-08-24 08:20 am Purchase |
2022-05-19 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
Nicholas Jason Singer | 1,445,448 5.170% |
1,445,448 (New Position) |
Filing History |
| 2023-08-16 06:04 am Purchase |
2022-05-19 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
OTR Acquisition Sponsor LLC | 796,208 2.900% |
796,208 (New Position) |
Filing History |
| 2023-08-10 3:27 pm Purchase |
2023-07-31 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
IAF, LLC | 2,736,015 9.900% |
2,736,015 (New Position) |
Filing History |
| 2023-08-03 7:54 pm Unchanged |
2023-07-31 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Soane David | 3,471,696 12.630% |
0 (Unchanged) |
Filing History |
| 2023-01-10 4:30 pm Purchase |
2023-01-04 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
Freebird Partners LP | 1,313,423 5.710% |
1,313,423 (New Position) |
Filing History |
| 2023-01-09 3:23 pm Purchase |
2023-01-02 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Soane David | 3,471,696 15.320% |
205,701 (+6.30%) |
Filing History |
| 2023-01-06 4:36 pm Purchase |
2023-01-02 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 4,434,410 18.700% |
2,304,636 (+108.21%) |
Filing History |
| 2022-10-28 2:38 pm Purchase |
2022-05-19 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Soane David | 3,265,995 17.100% |
3,265,995 (New Position) |
Filing History |
| 2022-09-13 09:42 am Purchase |
2022-05-19 | 13D | Comera Life Sciences Holdings, Inc. CMRA |
Charles Cherington | 2,129,774 11.200% |
2,129,774 (New Position) |
Filing History |
| 2022-06-16 12:55 pm Sale |
2022-06-10 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
Rabinowitz Michael | 0 0.000% |
-967,520 (Position Closed) |
Filing History |
| 2022-06-03 2:51 pm Purchase |
2022-05-19 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
Rabinowitz Michael | 967,520 5.900% |
967,520 (New Position) |
Filing History |
| 2022-05-31 5:22 pm Purchase |
2022-05-19 | 13G | Comera Life Sciences Holdings, Inc. CMRA |
Phoenix Venture Partners LP | 3,052,835 19.200% |
3,052,835 (New Position) |
Filing History |